Skip to main content
Premium Trial:

Request an Annual Quote

Roche Obtains CE Mark for Three Tests on New Cobas PCR Instrument

NEW YORK – Roche announced on Tuesday that it is launching three new tests on its molecular Cobas 5800 instrument in countries accepting the CE mark.

The RT-PCR tests for BK virus, cytomegalovirus, and Epstein-Barr virus received CE marking for use on the Cobas 5800 system in the last couple of weeks, a Roche spokesperson said via email. The tests are intended for use in transplant patients at risk of infection and can run simultaneously on the Cobas 5800.

Roche's Cobas BKV test received 510(k) clearance from the US Food and Drug Administration for use with its high-throughput Cobas 6800 and 8800 systems in 2020. The CMV test garnered FDA approval for the systems in 2017, and the Epstein-Barr virus test was cleared by the agency in 2020.

The existing test menu on the Cobas 5800 includes assays for hepatitis B, hepatitis C, HIV, and SARS-CoV-2, as well as multiplex tests for SARS-CoV-2 and influenza A/B, chlamydia and gonorrhea, and Trichomonas vaginalis and Mycoplasma genitalium.

The Cobas 5800 instrument, which delivers up to 144 results in an eight-hour shift, received CE marking last November.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.